Risk factors
Compass Pathways (CMPS) risk factors
Item 1A of every Compass Pathways plc 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors81 risks7 new18 dropped27 reworded
Clinical trial execution and commercial readiness for COMP360 psilocybin treatment dominate operational risks.
Filed Mar 24, 2026 - FY2024 10-K risk factors92 risks
Clinical-stage biotechnology company dependent entirely on the development of investigational COMP360 psilocybin treatment.
Filed Feb 27, 2025